Pharmafile Logo
Pharmafocus logo
Advanced Search
5204602349_c87b204860_z

Specialists petition FDA over opioid approval process

March 22, 2019
Medical Communications FDA, approval process, opioid crisis, opioids, painkillers

FDA officials have called on the federal agency to halt the approval of new narcotic painkillers. Dr Sidney Wolfe, a …

News

Tate art galleries will not accept donations from Sacklers

March 22, 2019
Medical Communications OxyContin, Purdue Pharma, Sacklers, Tate, art galleries, opioid crisis

The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the …

News
5789851635_d493d41b35_z

Department of Veteran Affairs to offer Janssen’s esketamine to veterans with depression

March 21, 2019
Medical Communications Jannsen, Spravato, VA, depression, esketamine, military, veteran affairs

The United States Department of Veteran Affairs (VA), the federal agency responsible for providing healthcare services to military veterans, is …

News

Breathing life into COPD research

March 21, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COPD, GSK, feature

Alison Hollands, Vice President, Respiratory, UK Pharmaceuticals at GlaxoSmithKline, addresses the importance of implementing the latest approaches to treating COPD …

Feature
eisa0008_web

Biogen and Eisai discontinue Phase 3 Alzheimer’s trial

March 21, 2019
Research and Development Alzheimer's, Biogen, CNS, Eisai, mental health

Biogen and Eisai have announced their decision to discontinue a Phase 3 trial looking into the efficacy and safety of …

News
celgene_1_02

Celgene inks drug discovery deal worth at least £25m with AI firm Exscientia

March 21, 2019
Research and Development Celgene, Exscientia, drug discovery, pharma

Celgene has entered into a new three-year partnership with British artificial intelligence and drug discovery firm Exscientia to the value …

News
mouse

J&J bows to PETA pressure and drops forced swim tests in mice

March 21, 2019
Medical Communications J&J, JJ, Johnson & Johnson, PETA, animal welfare, pharma

Johnson & Johnson has announced it is to end its practice of forced swim tests on mice, rats and other …

News
astrocyte5

Antiepileptics increase the risk of pneumonia in people with Alzheimer’s disease

March 21, 2019
Research and Development Alzheimer's, R&D, adverse events, antiepileptic drugs, epilepsy, pneumonia

Antiepileptic drugs increase the risk of pneumonia in people living with Alzheimer’s disease, according to research from the University of …

News
nguegvfjxvm8p1pck4yc38kuipa5nnez

Venezuela relaunch pharmaceutical industry with Chinese and Russian backing

March 21, 2019
Manufacturing and Production China, Maduro, Russia, USA, Venezuela, pharma

President Maduro has pledged to relaunch Venezuela’s pharmaceutical industry, as part of an effort to address shortages of medicines in …

News

Roche’s Tecentriq chalks up another FDA approval, this time in first-line extensive-stage small cell lung cancer

March 20, 2019
Research and Development, Sales and Marketing FDA, Roche, lung cancer, pharma, tecentriq

Roche has secured another US approval for its immunotherapy Tecentriq (atezolizumab), as the FDA reveals its approval of the drug …

News
roche_dark_0

FDA puts multiple myeloma trial on hold after patient deaths

March 20, 2019
Research and Development AbbVie, FDA, Roche, clinical trials, multiple myeloma

The FDA has placed a partial clinical hold on studies of multiple myeloma treatment Venclexta/Venclyxto (venetoclax) following a number of …

News

FDA approves first-ever postpartum depression therapy: Sage Therapeutics’ Zulresso

March 20, 2019
Research and Development, Sales and Marketing FDA, Sage Therapeutics, depression, pharma, postpartum depression

The FDA has announced its decision to approve Sage Therapeutics’ intraveneous injection Zulresso (brexanolone), marking the first authorisation of a …

News

Pfizer and Merck discontinue Phase 3 avelumab ovarian cancer trial

March 20, 2019
Research and Development Merck KGaA, Pfizer, javelin, oncology, ovarian cancer

Pfizer and Merck KGaA have chosen to discontinue the Phase 3 JAVELIN trial looking into avelumab in combination with chemotherapy …

News

Dame Sally Davies says medicinal cannabis legalisation has opened Pandora’s Box

March 20, 2019
Research and Development

England’s Chief Medical Officer (CMO), Dame Sally Davies has said the legalisation of medicinal cannabis has “opened a Pandora’s Box,” …

News
cancer-cells-541954_960_720

Breast cancer mortality rates fall faster in Britain than elsewhere in Europe

March 19, 2019
Manufacturing and Production, Research and Development Cancer, EU, Europe, France, Italy, Poland, UK, breast cancer, german, oncology

Death rates from breast cancer are falling faster in Britain than in any of the other six most populous countries …

News
astrazeneca_plaque

AZ’s Farxiga reduces major adverse cardiovascular event risk in type 2 diabetes, new data shows

March 19, 2019
Manufacturing and Production, Research and Development AstraZeneca, cardiovascular, farxiga, pharma

AstraZeneca has lifted the curtain on new Phase 3 data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin), reinforcing …

News

Shortage of cancer doctors puts NHS patients at risk

March 19, 2019
Manufacturing and Production, Research and Development Cancer, NHS, oncologists, radiology, shortfall, staff

A shortage of cancer doctors is putting patients at risk, according to a new report from the Royal College of …

News
allergan

FDA approves first paediatric treatment for intra-abdominal and urinary tract infections in over 10 years

March 19, 2019
Manufacturing and Production, Sales and Marketing Allergan, Avycaz, FDA, pharma

Allergan has revealed that Avycaz (ceftazidime and avibactam) has been awarded an expansion of its label by the FDA to include …

News
index_ph001

Daiichi Sankyo show positive results for atrial fibrillation treatment Lixiana

March 18, 2019
Manufacturing and Production, Research and Development Daiichi Sankyo, Lixiana, pharma, vitamin K antagonist

Japanese firm Daiichi Sankyo has announced positive results of the first randomised controlled trial of uninterrupted Lixiana (edoxoban) in atrial …

News
mme_fb_event_banner_tangent_dj

Patient Experience: Living with two rare diseases

March 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wyburn-Mason Syndrome, acromegaly, feature, patient experience, pharma, rare disease

Dan Jeffries was diagnosed with the ultra-rare condition Wyburn-Mason syndrome at a young age, leaving him blind in one eye. …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026